Is Oncology Institute, Inc. (TOIIW) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| DJIM | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| MSCI | 71.3% / 33% | 28.8% / 33% | 28.2% / 33% | 0.75% / 5% | ✗ NOT HALAL |
| S&P | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| FTSE | 71.3% / 33% | 28.8% / 33% | 28.2% / 50% | 0.75% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 15.2% | |
| Operating Margin | -4.9% | |
| Net Margin | -12.1% | |
| Return on Assets (ROA) | -13.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$25M |
| Free Cash Flow | -$28M |
| Total Debt | $104M |
| Current Ratio | 1.6 |
| Total Assets | $165M |
Price & Trading
| Last Close | $0.05 |
| Beta | 0.2 |
|
52-Week Range
$0.04
| |
About Oncology Institute, Inc. (TOIIW)
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Related Halal Stocks in
Frequently Asked Questions
Is Oncology Institute, Inc. (TOIIW) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Oncology Institute, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Oncology Institute, Inc.'s debt ratio?
Oncology Institute, Inc.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 71.3%.
What are Oncology Institute, Inc.'s key financial metrics?
Oncology Institute, Inc. has a market capitalization of N/A, and revenue of $503M. The company maintains a gross margin of 15.2% and a net margin of -12.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.